Completed PHASE4 INTERVENTIONAL 2-arm NCT00148031

Improving Hepatitis C Treatment in Injection Drug Users

Sponsor: State University of New York - Upstate Medical University

Conditions Alcoholism Drug Abuse Hepatitis C Liver Diseases

Interventions Off-site HCV evaluation and treatment On-site (MMT Clinic) HCV evaluation and treatment Pegylated Interferon and Ribavirin Psychosocial

Updated 6 times since 2017 Last updated: Apr 23, 2013 Started: Sep 30, 2003 Primary completion: Mar 31, 2007 Completion: Mar 31, 2007

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT00148031, this PHASE4 trial focuses on Alcoholism and Drug Abuse and remains completed. Sponsored by State University of New York - Upstate Medical University, it has been updated 6 times since 2003, reflecting limited change activity. This study is part of the global effort to build evidence for infectious disease interventions.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Jan 2021 — Jul 2024 [monthly]

Completed PHASE4
Jun 2018 — Jan 2021 [monthly]

Completed PHASE4
Feb 2017 — Jun 2018 [monthly]

Completed PHASE4

▶ Show 1 earlier version

Jan 2017 — Feb 2017 [monthly]

Completed PHASE4

First recorded

Sep 2003

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

State University of New York - Upstate Medical University

Data source: State University of New York - Upstate Medical University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Syracuse, United States